CVE-2025-33231 json
NVIDIA Nsight Systems for Windows contains a vulnerability in the application’s DLL loading mechanism where an attacker could cause an unco…
published 9mo ago modified 4mo ago also EUVD-2026-3375
- cvss
- 6.7
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.2%
- EPSS 0.2% chance of exploitation in 30 days, percentile 8%
- public exploits
- 0
- none known
Summary
NVIDIA Nsight Systems for Windows contains a vulnerability in the application’s DLL loading mechanism where an attacker could cause an uncontrolled search path element by exploiting insecure DLL search paths. A successful exploit of this vulnerability might lead to code execution, escalation of privileges, data tampering, denial of service and information disclosure.
Patch / fix
Is CVE-2025-33231 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.
Check with FencerCISA SSVC
- Exploitation
- none
- Automatable
- no
- Technical impact
- total
- Assessed
- 9mo ago
Exploit prediction
0.19% chance of exploitation in the next 30 days, higher than 8% of all scored CVEs (FIRST EPSS, 2026-11-09).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 6.7 | CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H |
Affected products
- NVIDIA CUDA Toolkit
Classification
- Weakness
-
- CWE-427 Uncontrolled Search Path Element
References
-
nvidia.custhelp.com
/app/answers/detail/a_id/5755
patch, vendor-advisory
-
nvd.nist.gov
/vuln/detail/CVE-2025-33231
us-government-resource, vdb-entry
-
cve.org
/CVERecord?id=CVE-2025-33231
third-party-advisory
Sources
- CVE List CVE-2025-33231
- NVD CVE-2025-33231
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.
CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.